These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31104548)

  • 1. Skin Complications Associated With Pediatric Central Venous Access Devices: Prevalence, Incidence, and Risk.
    Ullman AJ; Kleidon TM; Turner K; Gibson V; Dean A; Cattanach P; Pitt C; Woosley J; Marsh N; Gavin N; Takashima M; Rickard CM
    J Pediatr Oncol Nurs; 2019; 36(5):343-351. PubMed ID: 31104548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central venous access device adverse events in pediatric patients with cancer: a systematic review and meta-analysis.
    Nunn JL; Takashima MD; Wray-Jones EM; Soosay Raj TA; Hanna DMT; Ullman AJ
    Support Care Cancer; 2024 Sep; 32(10):662. PubMed ID: 39283363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Road map for improvement: Point prevalence audit and survey of central venous access devices in paediatric acute care.
    Ullman AJ; Cooke M; Kleidon T; Rickard CM
    J Paediatr Child Health; 2017 Feb; 53(2):123-130. PubMed ID: 27709723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
    Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
    BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin complications associated with vascular access devices: A secondary analysis of 13 studies involving 10,859 devices.
    Ullman AJ; Mihala G; O'Leary K; Marsh N; Woods C; Bugden S; Scott M; Rickard CM
    Int J Nurs Stud; 2019 Mar; 91():6-13. PubMed ID: 30658228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
    van den Bosch CH; van der Bruggen JT; Frakking FNJ; Terwisscha van Scheltinga CEJ; van de Ven CP; van Grotel M; Wellens LM; Loeffen YGT; Fiocco M; Wijnen MHWA
    J Pediatr Surg; 2019 Sep; 54(9):1894-1900. PubMed ID: 30415957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials.
    Ullman AJ; Kleidon T; Gibson V; Long DA; Williams T; McBride CA; Hallahan A; Mihala G; Cooke M; Rickard CM
    BMJ Open; 2016 Jun; 6(6):e011197. PubMed ID: 27259529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central venous access devices site care practices: an international survey of 34 countries.
    Broadhurst D; Moureau N; Ullman AJ
    J Vasc Access; 2016; 17(1):78-86. PubMed ID: 26349858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric central venous access devices: practice, performance, and costs.
    Ullman AJ; Gibson V; Takashima MD; Kleidon TM; Schults J; Saiyed M; Cattanach P; Paterson R; Cooke M; Rickard CM; Byrnes J; Chopra V
    Pediatr Res; 2022 Nov; 92(5):1381-1390. PubMed ID: 35136199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trial.
    Mollee P; Okano S; Abro E; Looke D; Kennedy G; Harper J; Clouston J; Van Kuilenburg R; Geary A; Joubert W; Eastgate M; Jones M
    J Hosp Infect; 2020 Oct; 106(2):335-342. PubMed ID: 32712388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of Central Venous Access Devices: A Systematic Review.
    Ullman AJ; Marsh N; Mihala G; Cooke M; Rickard CM
    Pediatrics; 2015 Nov; 136(5):e1331-44. PubMed ID: 26459655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
    Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
    Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Pediatric Central Venous Access Device Placement With Concomitant Surgical Procedures.
    Bludevich BM; Chandler NM; Gonzalez R; Danielson PD; Snyder CW
    J Surg Res; 2021 Mar; 259():451-457. PubMed ID: 33616076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term central venous access in a pediatric leukemia population.
    Fu AB; Hodgman EI; Burkhalter LS; Renkes R; Slone T; Alder AC
    J Surg Res; 2016 Oct; 205(2):419-425. PubMed ID: 27664891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a paediatric central venous access device database: A retrospective cohort study of practice evolution and risk factors for device failure.
    Kleidon TM; Rickard CM; Schults JA; Mihala G; McBride CA; Rudkin J; Chaseling B; Ullman AJ
    J Paediatr Child Health; 2020 Feb; 56(2):289-297. PubMed ID: 31436918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a Nurse-Led Protocol on Time to Treatment of Partial Occlusions in Central Venous Access Devices in Pediatric Oncology.
    Hunter A; Cunningham KS; Yuen C; Jensen K; Afzal A; Benzies K
    J Pediatr Oncol Nurs; 2020; 37(5):305-312. PubMed ID: 32639196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
    Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
    Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia Major.
    Ordóñez J; Del Cañizo A; Beléndez C; García-Morín M; Pérez-Egido L; Fanjul M; García-Casillas MA; Cerdá J; Peláez D; Bardón E; de Agustín JC; Cela E
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e655-e660. PubMed ID: 33093353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.